The Lilly TB Drug

Discovery Initiative

The Lilly TB Drug Discovery Initiative collaborates with outstanding scientists throughout the world to advance drug discovery.

The Lilly TB Drug Discovery Initiative is a non-profit public-private partnership with a mission to accelerate early-stage drug discovery and to develop clinical candidates by bringing together specialists from around the world for the systematic exploration of vast, private molecular libraries in search of new TB treatments.

Headquartered in Seattle, Washington, the Lilly TB Drug Discovery Initiative includes representatives from government, philanthropic organizations, pharmaceutical companies, universities, and other research institutions. Its most important goal is filling the pipeline with new TB drugs.
To learn more, visit: the Lilly TB Drug Discovery Initiative website.